Literature DB >> 29125944

HLA-A*31:01 and carbamazepine-induced DRESS syndrom in a sample of North African population.

Kamilia Ksouda1, Hanen Affes2, Nedia Mahfoudh3, Lassad Chtourou4, Arwa Kammoun3, Aida Charfi3, Hend Chaabane5, Molka Medhioub2, Zouhir Sahnoun2, Hamida Turki5, Nabil Tahri4, Serria Hammami2, Khaled Zeghal2.   

Abstract

PURPOSE: Drug rash with eosinophilia and systemic symptoms (DRESS) is a serious adverse drug reaction. Carbamazepine is the most common causes of this syndrome. The HLA-A*31:01 allele has been shown to be strongly correlated with carbamazepine-induced DRESS syndrome in European, Japanese, Han Chinese and other asian population but not in African populations. So, our purpose is to study there is a correlation between HLA-A*31:01 and carbamazepine-induced DRESS syndrome in africain population?
METHODS: HLA class I (A and B) typing was performed on 7 subjects with carbamazepine-DRESS syndrome and 25 tolerants controls subjects. DNA typing HLA class I (A) alleles was checked by the polymerase chain reaction amplification Sequence Specific Oligonucleotide Probes (SSO) (reverse-SSO assay). High resolution HLA DNA Kit based on the Luminex technology (One Lambda®) was used according to the manufacturer's protocol.
RESULTS: The HLA-A*31:01 allele, which has a prevalence of 1% in Tunisian population, was significantly associated with DRESS syndrome. It was detected in 57.14% of cases (4/7) and only 4% of controls subjects (1/25). Thus, the carrier frequency of HLA-A*31:01 allele in the cases group was also significantly higher than in the controls group (57, 14% vs 4% P = 0,004). Odds ratio is estimated 32 (OR = 32 [2.6; 389.2])
CONCLUSION: Similarly to other ethnicities, the presence of the HLA-A*31:01 allele was associated with carbamazepine-DRESS syndrome in a sample of North African population. Future study must be conducted on a larger sample in order to confirm these results.
Copyright © 2017 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Carbamazepine; Dress syndrome; HLA genotype

Mesh:

Substances:

Year:  2017        PMID: 29125944     DOI: 10.1016/j.seizure.2017.10.018

Source DB:  PubMed          Journal:  Seizure        ISSN: 1059-1311            Impact factor:   3.184


  4 in total

1.  Reporting of drug reaction with eosinophilia and systemic symptoms from 2002 to 2019 in the US Food and Drug Administration Adverse Event Reporting System.

Authors:  Sara Beth Bluestein; Roger Yu; Cosby Stone; Elizabeth J Phillips
Journal:  J Allergy Clin Immunol Pract       Date:  2021-05-24

Review 2.  Translational Pharmacogenomics: Discovery, Evidence Synthesis and Delivery of Race-Conscious Medicine.

Authors:  Brittney H Davis; Nita A Limdi
Journal:  Clin Pharmacol Ther       Date:  2021-07-29       Impact factor: 6.903

3.  Nivolumab-associated DRESS in a genetic susceptible individual.

Authors:  Luoyan Ai; Jie Gao; Shihai Zhao; Qian Li; Yue-Hong Cui; Qing Liu; Duojiao Wu; Yimei Wang; Xiaoshi Jin; Yuan Ji; Jingjie Li; Yiyi Yu; Tianshu Liu
Journal:  J Immunother Cancer       Date:  2021-10       Impact factor: 13.751

4.  Associations of HLA genetic variants with carbamazepine-induced cutaneous adverse drug reactions: An updated meta-analysis.

Authors:  Mohitosh Biswas; Maliheh Ershadian; John Shobana; Ai-Hoc Nguyen; Chonlaphat Sukasem
Journal:  Clin Transl Sci       Date:  2022-05-22       Impact factor: 4.438

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.